Sulfamethylthiazole

DB15882ExperimentalSmall molecule

Sulfamethylthiazole is an antibiotic indicated to prevent postoperative ocular infections or treat ocular infections. Sulfamethylthiazole is a sulfonamide antibacterial agent.

Mechanism: While the exact mechanism of action of sulfamethylthiazole has not been fully elucidated, it is likely to share the actions of other sulfonamides, such as the inhibition of carbonic anhydrase.
Curator reviewed · 2 references
Formula / weight: C₁₀H₁₁N₃O₂S₂ · 269.34 g/mol (avg)
Also known as: Sulfazole
Code names: Ciba 3753 · RP-146

Resolves to

Compound

UNIIR12OZ3O07FCAS515-59-3ChEBI135107

Structure

InChIKeyKJVQYDYPDFFJMP-UHFFFAOYSA-NSMILESCC1=CSC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1

What you can answer from here — as of September 12, 2026

3Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

1Marketed productAcross 1 country and 1 labeller

4+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Sulfamethylthiazole, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account